Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells
- 1 January 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 6 (1) , 334-345
- https://doi.org/10.1158/1535-7163.mct-06-0404
Abstract
Epidemiologic studies show a correlation between increased consumption of fruits and vegetables with reduced risk of ovarian cancer. One major bioactive compound found in cruciferous vegetables, particularly broccoli, is sulforaphane, derived from the breakdown of glucoraphanin. We observed potent antiproliferative effects of sulforaphane on human ovarian cancer cell line SKOV3 (IC50 40 μmol/L) and mouse ovarian cancer cell lines C3 and T3 (IC50 25 μmol/L each) by cell viability assays. The loss of viability is reflected by a down-regulation of cell cycle transition regulators cyclin D1, cyclin-dependent kinase 4 (cdk4), and cdk6. The upstream mediators of sulforaphane effects on the cell cycle in ovarian cancer are still unknown. However, because the Akt signal transduction pathway is overactivated in ovarian cancer, we investigated the effects of sulforaphane on this prosurvival pathway. Both total Akt protein and active phosphorylated levels of Akt (Ser473) and phosphoinositide 3-kinase were significantly decreased in sulforaphane-treated SKOV3, C3, and T3 cells with a concomitant inhibition of Akt kinase activity by sulforaphane in SKOV3 and C3 cells. This inhibitory effect of sulforaphane leads to a potent induction of apoptosis in all three cell lines, along with the cleavage of poly(ADP)ribose polymerase. Our study is the first to report the antiproliferative effects of sulforaphane in ovarian cancer and identifying the Akt pathway as a target of sulforaphane, with implications for the inhibition of carcinogenesis by diet-based chemoprevention. [Mol Cancer Ther 2007;6(1):334–45]Keywords
This publication has 33 references indexed in Scilit:
- Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis inApcminmiceThe FASEB Journal, 2006
- Synthetic dimer of indole‐3‐carbinol: Second generation diet derived anti‐cancer agent in hormone sensitive prostate cancerThe Prostate, 2005
- ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cellsCarcinogenesis: Integrative Cancer Research, 2005
- G1cell cycle progression and the expression of G1cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cellsAmerican Journal of Physiology-Cell Physiology, 2004
- Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell linesJournal of Cellular Physiology, 2004
- Induction of cytochrome P450, generation of oxidative stress and in vitro cell-transforming and DNA-damaging activities by glucoraphanin, the bioprecursor of the chemopreventive agent sulforaphane found in broccoliCarcinogenesis: Integrative Cancer Research, 2003
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Induction of ovarian cancer by defined multiple genetic changes in a mouse model systemCancer Cell, 2002
- Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment.Endocrine-Related Cancer, 2001
- Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian CarcinomasThe American Journal of Pathology, 2001